Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Reimbursement News » CMS Increases Payment Rates for High-Throughput SARS-CoV-2 Tests

CMS Increases Payment Rates for High-Throughput SARS-CoV-2 Tests

Apr 15, 2020
|
staff reporter

NEW YORK – The Centers for Medicare and Medicaid Services announced Wednesday it is increasing payments for high-throughput SARS-CoV-2 lab tests. 

CMS will pay $100 for SARS-CoV-2 diagnostic tests that use high-throughput technologies allowing for increased capacity and faster results. Labs can bill for these tests using code U0003 for PCR-based coronavirus tests and code U0004 for tests using any technique with high-throughput technology. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Analysis for the Long Term

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

Pricey, But Available

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Pilot Cancer Testing Program for Taiwan

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

PLOS Papers on TB Resistance, Squamous Cell Carcinoma Risk, MicroRNAs in SCC

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.